CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Open-market sale President and CEO sold 3,745 shares at $0.98 ($3,655)
- 4 Open-market sale Chief Financial Officer sold 1,558 shares at $0.98 ($1,521)
- 4 Open-market sale General Counsel sold 1,118 shares at $0.98 ($1,091)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 1,000,000 shares at an average $0.91 ($911,801)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K/A Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Impairment
Page 3 of 38 · 755 filings